| Hans-Günter Meyer-Thompson | HIV
Opioid use trajectory groups and changes in a physical health biomarker among HIV-positive and uninfected patients receiving opioid agonist treatment.
Opioid use trajectory groups and changes in a physical health biomarker among HIV-positive and uninfected patients receiving opioid agonist treatment.
McGinnis KA, Fiellin DA, Skanderson M, Hser YI, Lucas GM, Justice AC, Tate JP; VACS Project Group.
Drug Alcohol Depend. 2019 Sep 4;204:107511. doi: 10.1016/j.drugalcdep.2019.06.014.
Abstract